Postoperative tegafur–uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis-Reference-Cited by-同舟云学术

Postoperative tegafur–uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis

Published:2022-07-02 Issue:1 Volume:53 Page:135-144
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Miyata Ryo,Hamaji Masatsugu,Nakakura Akiyoshi,Morita Satoshi,Shimazu Yumeta,Ishikawa Masashi,Kayawake Hidenao,Menju Toshi,Sakaguchi Yasuto,Sonobe Makoto,Takahashi Mamoru,Aoyama Akihiro,Sumitomo Ryota,Huang Cheng-Long,Kono Tomoya,Miyahara Ryo,Matsumoto Akira,Katakura Hiromichi,Fukada Takahisa,Sakai Hiroaki,Kobayashi Masashi,Okumura Norihito,Date Naoki,Fujinaga Takuji,Miyamoto Ei,Nakagawa Tatsuo,Date Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00595-022-02546-z.pdf

Reference23 articles.

1. Butts CA, Ding K, Seymour L, Twumasi-Ankrah P, Graham B, Gandara D, et al. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol. 2010;28(1):29–34.

2. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzales-Larriba JL, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7(9):719–27.

3. Felip E, Altorki N, Zhou C, Csőszi T, Vynnychenko I, Goloborodko O, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet. 2021;398(10308):1344–57.

4. NCCN clinical practice guidelines in Oncology. Non-Small Cell Lung Cancer, Available at NCCN, https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf Accessed Dec 28, 2020.

5. Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv1–iv21.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Tegafur–Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study;Annals of Thoracic and Cardiovascular Surgery;2024-01-26

2. Oral uracil–tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early‐stage non‐small cell lung cancer patients;Cancer Medicine;2023-08-09